28 April 2017
News and Views
Links and Services
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine, reports the most recent issue of the Alimentary Pharmacology & Therapeutics.
Thiopurines maintain remission and modify disease course in inflammatory bowel disease.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors